Logo image of RYB

RYB EDUCATION INC-ADR (RYB) Stock Fundamental Analysis

NYSE:RYB - US74979W1018 - ADR

0.6912
-0.05 (-6.48%)
Last: 5/23/2022, 8:04:00 PM
Fundamental Rating

3

RYB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 72 industry peers in the Diversified Consumer Services industry. RYB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RYB is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year RYB was profitable.
RYB Yearly Net Income VS EBIT VS OCF VS FCFRYB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 0 20M -20M

1.2 Ratios

Industry RankSector Rank
ROA 3.72%
ROE 17.36%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RYB Yearly ROA, ROE, ROICRYB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 0 50 -50 100 150

1.3 Margins

Industry RankSector Rank
OM 3.9%
PM (TTM) 6.37%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RYB Yearly Profit, Operating, Gross MarginsRYB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 0 10 -10 20 -20 -30

4

2. Health

2.1 Basic Checks

RYB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RYB Yearly Shares OutstandingRYB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 10M 20M 30M
RYB Yearly Total Debt VS Total AssetsRYB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 0.21, we must say that RYB is in the distress zone and has some risk of bankruptcy.
There is no outstanding debt for RYB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.21
ROIC/WACCN/A
WACCN/A
RYB Yearly LT Debt VS Equity VS FCFRYB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 20M 40M 60M 80M 100M

2.3 Liquidity

RYB has a Current Ratio of 0.66. This is a bad value and indicates that RYB is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.61 indicates that RYB may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.66
Quick Ratio 0.61
RYB Yearly Current Assets VS Current LiabilitesRYB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 50M 100M 150M

6

3. Growth

3.1 Past

RYB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 123.19%, which is quite impressive.
Looking at the last year, RYB shows a very strong growth in Revenue. The Revenue has grown by 58.72%.
RYB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.76% yearly.
EPS 1Y (TTM)123.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.23%
Revenue 1Y (TTM)58.72%
Revenue growth 3Y-7.98%
Revenue growth 5Y5.76%
Sales Q2Q%31.52%

3.2 Future

RYB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.40% yearly.
Based on estimates for the next years, RYB will show a quite strong growth in Revenue. The Revenue will grow by 18.32% on average per year.
EPS Next Y103.23%
EPS Next 2Y42.78%
EPS Next 3Y26.8%
EPS Next 5Y15.4%
Revenue Next Year78.37%
Revenue Next 2Y39.63%
Revenue Next 3Y26.9%
Revenue Next 5Y18.32%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RYB Yearly Revenue VS EstimatesRYB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
RYB Yearly EPS VS EstimatesRYB Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -0.5 -1 -1.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 1.73, the valuation of RYB can be described as very cheap.
The average S&P500 Price/Earnings ratio is at 27.06. RYB is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 11.41, which indicates a very decent valuation of RYB.
RYB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 1.73
Fwd PE 11.41
RYB Price Earnings VS Forward Price EarningsRYB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -3.14
RYB Per share dataRYB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

RYB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as RYB's earnings are expected to grow with 26.80% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y42.78%
EPS Next 3Y26.8%

0

5. Dividend

5.1 Amount

No dividends for RYB!.
Industry RankSector Rank
Dividend Yield N/A

RYB EDUCATION INC-ADR

NYSE:RYB (5/23/2022, 8:04:00 PM)

0.6912

-0.05 (-6.48%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)05-11 2022-05-11/amc
Earnings (Next)06-11 2022-06-11/amc
Inst Owners8.54%
Inst Owner Change-0.13%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.07M
Analysts42.5
Price Target2.35 (239.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.73
Fwd PE 11.41
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB N/A
EV/EBITDA -3.14
EPS(TTM)0.4
EY57.87%
EPS(NY)0.06
Fwd EY8.77%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.52
BVpS2.39
TBVpSN/A
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 17.36%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 3.9%
PM (TTM) 6.37%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.66
Quick Ratio 0.61
Altman-Z 0.21
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)123.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.23%
EPS Next Y103.23%
EPS Next 2Y42.78%
EPS Next 3Y26.8%
EPS Next 5Y15.4%
Revenue 1Y (TTM)58.72%
Revenue growth 3Y-7.98%
Revenue growth 5Y5.76%
Sales Q2Q%31.52%
Revenue Next Year78.37%
Revenue Next 2Y39.63%
Revenue Next 3Y26.9%
Revenue Next 5Y18.32%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A